Alpine Associates Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Alpine Associates Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-808,900	Closed	-$78.4M	–	57
2019 Q3	$78.4M	Buy	808,900 +24,800	+3%	+$2.48M	2.57%	16
2019 Q2	$80.3M	Buy	784,100 +91,800	+13%	+$9.91M	2.36%	20
2019 Q1	$78.8M	Buy	+692,300	New	+$50.9M	2.6%	16

Alpine Associates Management's ONCE Position: Q4 2019 in Review

Alpine Associates Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 808,900 shares — an estimated $78.4M sold.

Alpine Associates Management first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $80.3M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Alpine Associates Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Alpine Associates Management sold 808,900 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $78.4M.
Alpine Associates Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Alpine Associates Management's Spark Therapeutics, Inc. Common Stock position peaked at $80.3M in Q2 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Alpine Associates Management's 13F filing for Q4 2019, filed 13 Feb 2020.